Clinical characteristics and epidemiology of pulmonary pseudallescheriasis

Ayse Serda Kantarcioglu1, Gerritis Sybren de Hoog, Josep Guarro

  • 1Department of Microbiology and Clinical Microbiology, Cerrahpasa Medical Faculty, 34303 Cerrahpasa, Istanbul, Turkey. s.kantarcioglu@superonline.com

Abstract

Insights

Pseudallescheria and Scedosporium fungi cause serious lung infections, ranging from colonization to invasive pneumonia. Invasive infections have higher mortality, particularly in immunocompromised individuals.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pseudallescheria (anamorph Scedosporium) species are increasingly recognized as significant human pathogens.
  • Pulmonary infections caused by these fungi range from airway colonization to invasive disease, with potential for dissemination, especially to the brain.
  • Infections manifest differently in immunocompetent versus immunocompromised individuals.

Purpose of the Study:

  • To review and analyze reported cases of Pseudallescheria/Scedosporium pulmonary infections.
  • To investigate geographical distribution, host immune status, infection types, clinical presentations, treatments, and outcomes.
  • To understand the spectrum of pulmonary disease caused by these fungi.

Main Methods:

  • Systematic review of published literature on Pseudallescheria/Scedosporium pulmonary infections.
  • Analysis of 189 reported cases.
  • Categorization of infections based on clinical manifestations, host immune status, and underlying conditions.

Main Results:

  • Pneumonia was the most common manifestation (89 cases), followed by fungus balls (26) and chest abscesses (18).
  • Near-drowning was associated with pneumonia in immunocompetent hosts.
  • Preexisting lung cavities and immunosuppression were linked to non-invasive and invasive pulmonary infections, respectively. Cystic fibrosis patients often presented with saprobic colonization.

Conclusions:

  • Pulmonary pseudallescheriasis presents with diverse clinical forms, including pneumonia, fungus balls, and abscesses.
  • Mortality rates were significantly higher in invasive infections (57.2%) compared to non-invasive types (26.8%).
  • Understanding host factors and infection type is crucial for managing these serious fungal infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...